These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14764863)

  • 1. The new math of clinical trials.
    Couzin J
    Science; 2004 Feb; 303(5659):784-6. PubMed ID: 14764863
    [No Abstract]   [Full Text] [Related]  

  • 2. Eligibility and extrapolation in cancer clinical trials.
    Begg CB; Engstrom PF
    J Clin Oncol; 1987 Jun; 5(6):962-8. PubMed ID: 3585451
    [No Abstract]   [Full Text] [Related]  

  • 3. [Why is it sometimes necessary to include a large number of patients in clinical trials?].
    Hill C
    Bull Cancer; 1989; 76(6):569-71. PubMed ID: 2570613
    [No Abstract]   [Full Text] [Related]  

  • 4. Jerome Cornfield's contributions to the conduct of clinical trials.
    Ederer F
    Biometrics; 1982 Mar; 38 Suppl():25-32. PubMed ID: 7046822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern concepts of the natural history of breast cancer: a guide to the design and publication of trials of the treatment of breast cancer.
    Baum M
    Eur J Cancer; 2013 Jan; 49(1):60-4. PubMed ID: 22884336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of information on drug resistance on protocol design.
    DeVita VT
    Ann Oncol; 1991 Feb; 2(2):93-106. PubMed ID: 2054322
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor re Yu and Holmgren. Traditional endpoint of progression-free survival (PFS) may not be appropriate for evaluating cytostatic agents combined with chemotherapy in cancer clinical trials.
    Mietlowski W; Wang J
    Contemp Clin Trials; 2007 Sep; 28(5):674. PubMed ID: 17449334
    [No Abstract]   [Full Text] [Related]  

  • 8. TAILORx: trial assigning individualized options for treatment (Rx).
    Sparano JA
    Clin Breast Cancer; 2006 Oct; 7(4):347-50. PubMed ID: 17092406
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpretation of results of chemotherapy trials in metastatic breast cancer.
    J Clin Oncol; 1986 Feb; 4(2):258-61. PubMed ID: 3511185
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients' concerns about clinical trials in Japan.
    Aoki E
    Lancet; 1999 Mar; 353(9157):1019-20. PubMed ID: 10459946
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.
    Alvarez RH; Hortobagyi GN
    Breast Cancer Res Treat; 2010 Dec; 124(3):701-5. PubMed ID: 20953832
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni Bonadonna.
    DeVita VT; Canellos GP
    Tumori; 2016; 102(2):124-6. PubMed ID: 27002947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.
    Schlesselman JJ
    J R Soc Med; 2016 Jan; 109(1):27-35. PubMed ID: 26801994
    [No Abstract]   [Full Text] [Related]  

  • 14. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician.
    Chertow GM; Palevsky PM; Greene T
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1124-7. PubMed ID: 17699335
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy for metastatic breast cancer.
    Nabholtz JM; Reese DM; Lindsay MA; Riva A
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):169-80. PubMed ID: 12113239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy in early breast cancer.
    Chittoor SR; Swain SM
    Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical trials of the Organisation for Oncology and Translational Research (OOTR).
    Chow LW; Toi M
    Int J Biol Markers; 2012 Dec; 27(4):e353-6. PubMed ID: 23250776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
    Berry DA; Inoue L; Shen Y; Venier J; Cohen D; Bondy M; Theriault R; Munsell MF
    J Natl Cancer Inst Monogr; 2006; (36):30-6. PubMed ID: 17032892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inference and decision in clinical trials.
    Armitage P
    J Clin Epidemiol; 1989; 42(4):293-9. PubMed ID: 2723689
    [No Abstract]   [Full Text] [Related]  

  • 20. Speed SPYing: adaptive clinical trials hit the gas.
    Zipkin M
    Nat Biotechnol; 2019 Sep; 37(9):975-977. PubMed ID: 31485040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.